Equillium (EQ) vs ProMIS Neurosciences (PMN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Equillium (EQ) has outperformed ProMIS Neurosciences (PMN) over the past year, losing 6.7% versus a loss of 32.4%. Over five years, EQ leads with a -76.5% price change compared with -95.9% for PMN. Equillium is the larger company by market cap ($90.0 million vs $78.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EQ | PMN |
|---|---|---|
| Share price | $1.42 | $8.80 |
| Market cap | $90.04M | $78.92M |
| 1-day change | +2.17% | -3.51% |
| YTD return | -10.32% | +33.53% |
| 1-year return | -6.71% | -32.44% |
| 5-year return | -76.48% | -95.95% |
| EPS (TTM) | $-0.14 | $-11.65 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.54 | $27.40 |
| 52-week low | $0.76 | $6.27 |
| Distance from 52-week high | -59.89% | -67.88% |
| Average volume | 614.50K | 84.01K |
| Shares outstanding | 63.41M | 8.97M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- EQ has outperformed PMN by 25.7 percentage points over the past year.
EQ vs PMN FAQ
Which is bigger, Equillium or ProMIS Neurosciences?
Equillium (EQ) is larger, with a market capitalization of $90.04M compared with $78.92M for ProMIS Neurosciences (PMN).
Which stock has performed better over the past year, EQ or PMN?
EQ returned -6.71% over the past 12 months, compared with -32.44% for PMN (price return, excluding dividends). Past performance does not predict future results.
Are Equillium and ProMIS Neurosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.